세계의 지중해 빈혈 치료 시장 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Thalassemia Treatment Market (Treatment Type: Blood Transfusion, Chelation Therapy, Bone Marrow Transplantation, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1459803
리서치사:Transparency Market Research
발행일:2024년 02월
페이지 정보:영문 193 Pages
라이선스 & 가격 (부가세 별도)
한글목차
지중해 빈혈 치료 시장 : 조사 범위
TMR사의 조사 보고서 「세계 지중해 빈혈 치료 시장」은 2023년부터 2031년까지의 예측 기간에 있어서 시장 지표에 대해서 귀중한 인사이트을 얻기 위해, 과거뿐만 아니라 현재의 성장 동향과 기회에 대해서도 조사해 있습니다. 본 보고서는 2023년을 기준년, 2031년을 예측년으로, 2017년부터 2031년까지 세계 지중해 빈혈 치료 시장의 수익과 예측을 제공합니다. 또한 2023년부터 2031년까지 세계 지중해 빈혈 치료 시장의 복합 연간 성장률(CAGR)도 제공합니다.
이 보고서는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체와의 인터뷰를 실시했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조하여 사라세미아 치료 시장을 이해했습니다.
시장 현황
2022년 시장가치
7억 9,180만 달러
2031년 시장가치
15억 달러
복합 연간 성장률(CAGR)
7.3%
이 보고서는 세계 지중해 빈혈 치료 시장 경쟁 구도에 대해 파악하고 있습니다. 세계 지중해 빈혈 치료 시장에서 사업을 전개하는 주요 기업이 확인되고 각 기업이 다양한 속성으로 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 시장 개척, SWOT는 본 보고서에 소개된 세계 지중해 빈혈 치료 시장에서 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약: 시장
제4장 시장 개요
소개
시장 개요
시장 역학
시장 분석과 예측(2017년-2031년)
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19 팬데믹의 산업에 대한 영향
제6장 시장 분석과 예측 : 치료 유형별
소개 및 정의
주요 조사 결과/발전
시장 매출 예측 : 치료 유형별(2017년-2031년)
수혈요법
킬레이션 요법
골수 이식
기타
시장 매력도 분석 : 치료 유형별
제7장 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 :지역별(2017년-2031년)
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력도 분석 :지역별
제8장 북미 시장 분석과 예측
제9장 유럽 시장 분석과 예측
제10장 아시아태평양 시장 분석과 예측
제11장 라틴아메리카 시장 분석과 예측
제12장 중동 및 아프리카 시장 분석과 예측
제13장 경쟁 구도
시장 경쟁 매트릭스(티어별,기업 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 프로파일
Bluebird Bio, Inc.
Merck & Co., Inc.
Novartis AG
Celgene Corporation
Takeda Pharmaceuticals Company Limited
Incyte Corporation
Sanofi
Bellicum Pharmaceuticals
GSK plc
BJH
영문 목차
영문목차
Thalassemia Treatment Market - Scope of Report
TMR's report on the global thalassemia treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thalassemia treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thalassemia treatment market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thalassemia treatment market.
Market Snapshot
Market Value in 2022
US$ 791.8 Mn
Market Value in 2031
US$ 1.5 Bn
CAGR
7.3%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thalassemia treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thalassemia treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thalassemia treatment market.
The report delves into the competitive landscape of the global thalassemia treatment market. Key players operating in the global thalassemia treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thalassemia treatment market profiled in this report.
Key Questions Answered in Global thalassemia treatment Market Report:
What is the sales/revenue generated by thalassemia treatment across all regions during the forecast period?
What are the opportunities in the global thalassemia treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Thalassemia Treatment Market - Research Objectives and Research Approach
The comprehensive report on the global thalassemia treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global thalassemia treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thalassemia treatment market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Thalassemia Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Thalassemia Treatment Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Thalassemia Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017-2031
6.3.1. Blood Transfusion
6.3.2. Chelation Therapy
6.3.3. Bone Marrow Transplantation
6.3.4. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Thalassemia Treatment Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region, 2017-2031
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Thalassemia Treatment Market Analysis and Forecast
8.1. Introduction
8.2. Key Findings
8.3. Market Value Forecast, by Treatment Type, 2017-2031
8.3.1. Blood Transfusion
8.3.2. Chelation Therapy
8.3.3. Bone Marrow Transplantation
8.3.4. Others
8.4. Market Value Forecast, by Country, 2017-2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Treatment Type
8.5.2. By Country
9. Europe Thalassemia Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Treatment Type, 2017-2031
9.3.1. Blood Transfusion
9.3.2. Chelation Therapy
9.3.3. Bone Marrow Transplantation
9.3.4. Others
9.4. Market Value Forecast, by Country/Sub-region, 2017-2031
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Treatment Type
9.5.2. By Country/Sub-region
10. Asia Pacific Thalassemia Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Treatment Type, 2017-2031
10.3.1. Blood Transfusion
10.3.2. Chelation Therapy
10.3.3. Bone Marrow Transplantation
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Treatment Type
10.5.2. By Country/Sub-region
11. Latin America Thalassemia Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Treatment Type, 2017-2031
11.3.1. Blood Transfusion
11.3.2. Chelation Therapy
11.3.3. Bone Marrow Transplantation
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Treatment Type
11.5.2. By Country/Sub-region
12. Middle East & Africa Thalassemia Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Treatment Type, 2017-2031
12.3.1. Blood Transfusion
12.3.2. Chelation Therapy
12.3.3. Bone Marrow Transplantation
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
12.5.1. By Treatment Type
12.5.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
